MedTech News
AI-radar system tracks subtle health changes by assessing patient’s walk
Engineering and health researchers at the University of Waterloo have developed a radar and artificial intelligence (AI) system that can monitor multiple people walking in busy hospitals and long-term care facilities to identify possible health issues.
Remedy Robotics unveils remotely operable endovascular surgical robot
Remedy Robotics announced that it debuted the N1 system, a remotely operable endovascular surgical robotic system.
Vektor Medical wins CE mark for AI-based arrhythmia mapping system
Vektor Medical today announced it received CE mark approval for its vMap artificial intelligence-powered arrhythmia mapping system.
Medtronic launches full U.S. distribution of Neuroguard IEP carotid stent system
Medtronic (NYSE: MDT)+
today announced the full U.S. rollout of the Neuroguard IEP system, a carotid stent and embolic protection device.
Medtronic launches VitalFlow ECMO in Europe
Medtronic (NYSE: MDT)+
announced today that it kicked off the European launch of its VitalFlow one-system ECMO solution.
Antibody discovered that blocks almost all known HIV variants in neutralization assays
An international research team led by the University of Cologne has discovered an antibody that could advance the fight against HIV. The newly identified antibody 04_A06 proved to be particularly effective in laboratory tests. It was able to neutralize 98.5% of more than 300 different HIV strains, making it one of the broadest antibodies against HIV identified.
Drug discovery platform yields optimized compound against SARS-CoV-2 and shows promise against other RNA-based viruses
In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus that causes COVID-19.
Tosoh Announces 510k Clearance for Highly Anticipated Next-Generation GR01 HbA1c Analyzer: A Fast, Accurate and Efficient Solution for A1c Testing
GROVE CITY, Ohio, Oct. 6, 2025 /PRNewswire/ — Tosoh Bioscience, Inc., a market leader in clinical diagnostics is proud to announce that it has received US FDA 510(k) clearance for its next-generation system for HbA1c testing – the Tosoh Automated Glycohemoglobin Analyzer HLC®723-GR01 (hereafter “GR01”). The GR01 is intended for monitoring the long-term blood glucose control of individuals with diabetes, as an aid in the diagnosis of diabetes and to help identify those who may be at risk of developing the disease.